Invention Grant
- Patent Title: Anti-Ror2 antibodies, antibody fragments, their immunoconjugates and uses thereof
-
Application No.: US16088769Application Date: 2017-05-12
-
Publication No.: US11254742B2Publication Date: 2022-02-22
- Inventor: Jay M. Short , Hwai Wen Chang , Gerhard Frey
- Applicant: BioAtla, LLC
- Applicant Address: US CA San Diego
- Assignee: BioAtla, LLC
- Current Assignee: BioAtla, LLC
- Current Assignee Address: US CA San Diego
- Agency: Mendelsohn Dunleavy, P.C.
- International Application: PCT/US2017/032357 WO 20170512
- International Announcement: WO2017/197234 WO 20171116
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; A61K47/68 ; A61P35/00 ; A61K38/07 ; A61K39/00
Abstract:
A polypeptide having a heavy chain variable region and/or light chain variable region that specifically binds to Ror2 protein as well as antibodies and antibody fragments containing the heavy chain variable region and/or the light chain variable region that bind to Ror2 protein. Pharmaceutical compositions and kits comprising the polypeptide or antibodies and antibody fragments containing the polypeptide are also provided.
Public/Granted literature
- US20200002414A1 ANTI-ROR2 ANTIBODIES, ANTIBODY FRAGMENTS, THEIR IMMUNOCONJUCATES AND USES THEREOF Public/Granted day:2020-01-02
Information query
